Patients with dyssynchronous yet feasible ventricles are most probable to benefit from cardiac resynchronization therapy in combination with defibrillation, concludes the most recent analysis of the MADIT CRT trial.

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial.

RICHMOND, Va., May 23, 2011 /PRNewswire/ -- CRT/tanaka, an award-winning public relations and marketing firm known for its whatcanbe workplace culture and approach to business, has announced its 2011 whatcanbe Award winners.

NEW YORK, May 12, 2011 /PRNewswire-USNewswire/ -- The Coalition for Responsible Transportation (CRT) today congratulated Rick Gabrielson for receiving the two most prestigious honors in the international shipping industry in recognition of his remarkable leadership and achievements within the field. Last night, Mr.

Esophagectomy is a standard treatment for resectable esophageal carcinoma but relatively few patients are cured.